Affymax, Inc. (AFFY)

0.0007 0.0000 (0.00%) At close: 10:37AM EDT

Affymax, Inc.

630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
650 812 8700
https://www.affymax.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mark G. Thompson	CFO & Secretary	97.49k	N/A	1962
Mr. Jonathan M. Couchman	CEO, President & Director	N/A	N/A	1970
Dr. Tracy J. Dunn Ph.D., J.D.	Vice President of Intellectual Property & Legal Affairs	N/A	N/A	1963

Amounts are as of 31 December 2013, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Corporate governance

Affymax, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.